Preclinical Study Reveals Potential Role for GLP-Agonists in

Danielle Krause, MD, discusses preclinical findings from mouse models evaluating GLP-1 agonists with and without progesterone in endometrial cancer.

Related Keywords

Oklahoma , United States , Oklahoma City , Danielle Krause , Ou Health Stephenson Cancer Center , Foundation For Women Cancer , Stephenson Cancer Center , Glucagon Like Peptide 1 , Glp 1 Agonist , Ozempic , Semaglutide , Endometrial Cancer , Glp 1 Receptor , Obesity Associated Mouse Model , Progesterone , Sgo 2024 Winter Meeting , D ,